Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Atea Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 142
- +39 vs. Q2 2021
- Shares held
- 56.8M
- −2.00M (−3.4%) vs. Q2 2021
- Total value
- $1.99B
- +$728.2M (+57.6%) vs. Q2 2021
- New holders
- 56
- 42 more added
- Sold out
- 17
- 31 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $276.4M |
| Q1 2026 | 127 | $322.8M |
| Q4 2025 | 111 | $203.5M |
| Q3 2025 | 115 | $154.2M |
| Q2 2025 | 107 | $189.7M |
| Q1 2025 | 104 | $158.3M |
| Q4 2024 | 107 | $188.7M |
| Q3 2024 | 108 | $194.0M |
| Q2 2024 | 105 | $187.7M |
| Q1 2024 | 113 | $219.6M |
| Q4 2023 | 108 | $168.3M |
| Q3 2023 | 119 | $170.6M |
| Q2 2023 | 133 | $213.3M |
| Q1 2023 | 131 | $190.2M |
| Q4 2022 | 131 | $278.1M |
| Q3 2022 | 126 | $326.8M |
| Q2 2022 | 128 | $408.7M |
| Q1 2022 | 127 | $396.6M |
| Q4 2021 | 143 | $479.2M |
| Q3 2021 | 142 | $1.99B |
| Q2 2021 | 104 | $1.27B |
| Q1 2021 | 82 | $3.20B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Atea Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Soleus Capital Management, L.P. | 117,600 | $4.12M | 0.64% | +117,600 | New |
| Emerald Mutual Fund Advisers Trust | 123,877 | $4.34M | 0.15% | +123,877 | New |
| Canada Pension Plan Investment Board | 138,000 | $4.84M | 0.01% | +138,000 | New |
| Russell Investments Group, Ltd. | 142,514 | $4.93M | 0.01% | +140,818+8,302.9% | Added |
| Putnam Investments LLC | 141,520 | $4.96M | 0.01% | +141,520 | New |
| Ghost Tree Capital, LLC | 150,000 | $5.26M | 1.73% | +150,000 | New |
| Discovery Capital Management, LLC | 162,800 | $5.71M | 0.43% | +162,800 | New |
| Omega Fund Management, LLC | 164,577 | $5.77M | 0.65% | −582,291−78.0% | Reduced |
| Congress Asset Management Co | 167,701 | $5.88M | 0.05% | +13,435+8.7% | Added |
| Emerald Advisers, LLC | 173,950 | $6.10M | 0.22% | +173,950 | New |
| Arrowstreet Capital, Limited Partnership | 178,555 | $6.26M | 0.01% | +47,695+36.4% | Added |
| Frontier Capital Management Co LLC | 179,346 | $6.29M | 0.05% | +179,346 | New |
| Woodline Partners LP | 185,265 | $6.50M | 0.11% | −2,540−1.4% | Reduced |
| Voloridge Investment Management, LLC | 257,416 | $9.03M | 0.06% | −21,034−7.6% | Reduced |
| Bank of New York Mellon Corp | 259,274 | $9.09M | 0.00% | +62,999+32.1% | Added |
| Nuveen Asset Management, LLC | 268,690 | $9.42M | 0.00% | −33,550−11.1% | Reduced |
| Wells Fargo & Company | 281,719 | $9.88M | 0.00% | +281,441+101,237.8% | Added |
| Manufacturers Life Insurance Company, The | 283,423 | $9.94M | 0.01% | −3,417−1.2% | Reduced |
| PFM Health Sciences, LP | 302,532 | $10.6M | 0.34% | +302,532 | New |
| Oracle Investment Management Inc | 309,126 | $10.8M | 1.36% | +309,126 | New |
| Invesco Ltd. | 317,579 | $11.1M | 0.00% | +295,781+1,356.9% | Added |
| Point72 Asset Management, L.P. | 332,200 | $11.6M | 0.06% | +332,200 | New |
| Marshall Wace, LLP | 339,553 | $11.9M | 0.06% | +240,847+244.0% | Added |
| Charles Schwab Investment Management Inc | 393,179 | $13.8M | 0.00% | +196,840+100.3% | Added |
| Adage Capital Partners GP, L.L.C. | 422,210 | $14.8M | 0.03% | −475,000−52.9% | Reduced |
| Banque Pictet & Cie SA | 438,596 | $15.4M | 0.16% | −56,481−11.4% | Reduced |
| Morgan Stanley | 442,686 | $15.5M | 0.00% | −346,662−43.9% | Reduced |
| Northern Trust Corp | 591,361 | $20.7M | 0.00% | +70,939+13.6% | Added |
| Goldman Sachs Group Inc | 713,225 | $25.0M | 0.01% | +333,001+87.6% | Added |
| Rock Springs Capital Management LP | 750,307 | $26.3M | 0.55% | −40,826−5.2% | Reduced |
| Geode Capital Management, LLC | 1,032,596 | $36.2M | 0.00% | +355,543+52.5% | Added |
| State Street Corp | 1,102,852 | $38.7M | 0.00% | +141,085+14.7% | Added |
| Price T Rowe Associates Inc | 1,495,965 | $52.4M | 0.00% | −195,517−11.6% | Reduced |
| AJU IB Investment Co., Ltd. | 1,637,331 | $57.4M | 37.04% | −108,000−6.2% | Reduced |
| Viking Global Investors LPSuperinvestorViking Global Investors | 1,655,087 | $58.0M | 0.16% | +1,655,087 | New |
| Perceptive Advisors LLC | 2,259,224 | $79.2M | 1.15% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 3,700,000 | $129.7M | 8.05% | −1,915,659−34.1% | Reduced |
| BlackRock Inc. | 4,136,801 | $145.0M | 0.00% | +645,838+18.5% | Added |
| Cormorant Asset Management, LP | 4,928,756 | $172.8M | 7.02% | −1,482,599−23.1% | Reduced |
| Vanguard Group Inc | 5,179,955 | $181.6M | 0.00% | +643,792+14.2% | Added |
| Ra Capital Management, L.P. | 5,427,655 | $190.3M | 2.64% | +59,204+1.1% | Added |
| FMR LLC | 12,416,533 | $435.3M | 0.03% | +6,0030.0% | Added |
| ABG Innovation Capital Partners III GP Ltd | 0 | $0 | 0.00% | −1,265,631−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −615,500−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −538,884−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −399,227−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −373,288−100.0% | Sold out |
| Redmile Group, LLC | 0 | $0 | 0.00% | −237,360−100.0% | Sold out |
| Fan Yu | 0 | $0 | 0.00% | −143,867−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −66,875−100.0% | Sold out |
| Ameraudi Asset Management, Inc. | 0 | $0 | 0.00% | −65,000−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −37,313−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −22,848−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −20,866−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −14,375−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −13,900−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −4,870−100.0% | Sold out |
| Bellwether Advisors, LLC | 0 | $0 | 0.00% | −116−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Pictet Asset Management Ltd | – | – | – | – | Not filed |